Philadelphia Inquirer Examines Effect Of Merck’s Failed International HIV Vaccine Trial On Research And Development
Oct 11th 2007Drug InformationHIV / AIDS
Merck’s decision last month to halt its international HIV vaccine trial was not a “definitive blow” to HIV vaccine research and development, but it created questions about whether research was “careening down the wrong path,” the [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
